ClinicalTrials.gg
Not yet recruitingNCT07800793Updated Sep 17, 2026

Effects of a Mobile Game in Menopausal Women

An interventional study of Menopause Mobile Game in Menopause, Brain Fog and Psychological Well-being, sponsored by Medipol University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to female participants aged 45 Years to 55 Years. Per ClinicalTrials.gov, last updated 2026-09-17.

Sponsored by Medipol University · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
82
Allocation
Randomized
Ages
45 Years to 55 Years
Sex
Female
01

Study summary

The goal of this clinical trial is to evaluate the effect of a mobile game-based cognitive intervention on brain fog and psychological well-being in menopausal women aged 45-55 years. The main questions it aims to answer are:

Are Brain Fog Scale scores lower among women in the mobile game intervention group compared with women in the control group? Are Warwick-Edinburgh Mental Well-Being Scale scores higher among women in the mobile game intervention group compared with women in the control group? Do women participating in the mobile game intervention demonstrate greater reductions in Brain Fog Scale scores and greater improvements in Warwick-Edinburgh Mental Well-Being Scale scores after the intervention compared with their baseline measurements?

Researchers will compare participants receiving the mobile game-based cognitive intervention with participants receiving routine follow-up only to determine the effectiveness of the intervention on brain fog and psychological well-being.

Participants will:

Complete baseline assessments using the Brain Fog Scale and the Warwick-Edinburgh Mental Well-Being Scale.

Be randomly assigned to either the intervention group or the control group. Use the cognitive training mobile game for 15 minutes per day, 5 days per week, for 6 weeks if assigned to the intervention group.

Receive routine follow-up only if assigned to the control group. Complete post-intervention assessments at the end of the 6-week study period.

Read the detailed description

Menopause is a natural stage in a woman's life characterized by hormonal changes that may affect physical, psychological, and cognitive health. In addition to vasomotor symptoms, many women report cognitive difficulties during the menopausal transition, commonly referred to as "brain fog." Brain fog encompasses subjective experiences such as reduced concentration, forgetfulness, slower information processing, and difficulties in maintaining attention. These cognitive challenges may negatively influence daily functioning, work productivity, self-confidence, and overall quality of life.

Psychological well-being is another important aspect of women's health during menopause. Hormonal fluctuations, aging-related changes, and psychosocial factors may contribute to declines in well-being. Cognitive difficulties and psychological well-being are closely interrelated, as persistent cognitive concerns may increase emotional distress and negatively affect individuals' perceptions of their mental health and well-being.

Digital health interventions have gained increasing attention as accessible and scalable approaches for supporting health promotion and symptom management. Among these interventions, mobile games offer opportunities to engage users through interactive and motivating activities while facilitating learning and cognitive stimulation. Cognitive training exercises delivered through mobile games may support cognitive functions such as attention, working memory, cognitive flexibility, verbal fluency, and visual memory. However, evidence regarding the effectiveness of mobile game-based cognitive interventions specifically designed for menopausal women remains limited.

The mobile game used in this study was developed to provide cognitive training through gamified activities targeting multiple cognitive domains. The intervention incorporates structured exercises intended to support attention, memory, problem-solving, and cognitive flexibility while promoting sustained engagement through an interactive digital format.

This study will investigate whether participation in a mobile game-based cognitive intervention can improve cognitive functioning related to brain fog and enhance psychological well-being among menopausal women. The findings are expected to contribute to the growing evidence base on non-pharmacological digital interventions and may support the development of accessible, low-cost, and sustainable approaches for promoting cognitive and psychological health during menopause.

02

Conditions studied

  • Menopause
  • Brain Fog
  • Psychological Well-being

Keywords

  • menopause
  • brain fog
  • psychological well-being
03

In context

Mental Fatigue

175 studies on the registry are indexed under Mental Fatigue; 54 are open to participants now.

This study's planned enrollment of 82 is above the median of 45 across 143 interventional studies indexed under Mental Fatigue.

Browse Mental Fatigue studies →

Lead sponsor

Medipol University is the lead sponsor of 326 studies on the registry; 88 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
45 Years to 55 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Women aged 45-55 years
  • Able to read and write in Turkish
  • Able to use a smartphone (Android or iOS)
  • Amenorrhea for at least 12 months
  • Willing to participate and provide written

Exclusion criteria

Exclusion Criteria:

  • Diagnosis of serious neurological disorders such as dementia, Alzheimer's disease, epilepsy, or multiple sclerosis
  • Diagnosis of severe psychiatric disorders such as major depression, bipolar disorder, or schizophrenia
  • Regular use of medications that may significantly affect cognitive function, including antiepileptics, antiparkinsonian drugs, antipsychotics, or antidepressants
  • Participation in cognitive training, memory training, or a similar digital intervention within the last 6 months
  • Visual, auditory, or motor impairments that would prevent the use of the mobile application
  • Participants scoring within the lowest 25% quartile (Q1) on the Brain Fog Scale
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
82 participants (estimated)

Study arms

  • Experimental
    Menopause Mobile Game Intervention

    Participants will use a mobile game developed to address brain fog symptoms during menopause.

    Behavioral: Menopause Mobile Game

  • No intervention
    Routine Care Control

    Participants will receive routine care and will not use the mobile game during the study period.

Interventions

  • BehavioralMenopause Mobile Game

    Participants in the intervention group will use a mobile game specifically designed for menopausal women to support cognitive functioning. The game includes interactive exercises and activities targeting attention, memory, processing speed, and other cognitive skills. Participants will use the mobile game throughout the intervention period in addition to routine care.

    Also known as: Menopause Education and Self-Management Mobile Game

06

What researchers measure

Primary outcomes

  1. Brain fog

    Change in Brain Fog Scale total score from baseline to post-intervention. The Brain Fog Scale is a 30-item instrument assessing cognitive, physical, and psychological symptoms of brain fog. Total scores range from 30 to 150, with higher scores indicating greater brain fog severity (worse outcome).

    Time frame: Baseline and Week 6

Secondary outcomes

  1. Change in Warwick-Edinburgh Mental Well-Being

    The effect of the mobile game intervention on psychological well-being among menopausal women will be assessed using the Warwick-Edinburgh Mental Well-Being Scale. Total scores range from 14 to 70, with higher scores indicating better mental well-being. Changes in total scores from baseline to Week 6 will be evaluated.

    Time frame: Baseline and Week 6

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No — Individual participant data (IPD) will not be publicly shared because the study involves sensitive health-related information collected from participants. Data will be used solely for the purposes of this research and will be reported in aggregate form to protect participant confidentiality.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Oct 2026; primary completion for Sep 2027, 11 months later.

Of 80 non-industry interventional studies with no phase under Mental Fatigue, half reached primary completion within 9 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 23. This study's planned 11 months is above that.

Counting every sponsor, half of 92 studies reached it within 8 months; a quarter within 3 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 30, 2026
First posted
Sep 2, 2026
StartEst.
Oct 15, 2026
Primary completionEst.
Sep 15, 2027
CompletionEst.
Dec 15, 2027
Last update
Sep 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07800793
Lead sponsor
Medipol University
Responsible party
Nazire Bahar (Lecturer, Medipol University) — Principal investigator
First posted
Sep 2, 2026
Start date
Oct 15, 2026 (estimated)
Primary completion
Sep 15, 2027 (estimated)
Completion
Dec 15, 2027 (estimated)
Last update
Sep 17, 2026

Study contacts

Nazire BAHAR
Contact
naziresel@gmail.com
905540070907
Nazire BAHAR
principal investigator · Istanbul Universitesi-Cerrahpasa

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion